Details for New Drug Application (NDA): 212279
✉ Email this page to a colleague
NDA 212279 describes EXEM FOAM KIT, which is a drug marketed by Giskit and is included in one NDA. It is available from one supplier. There are three patents protecting this drug. Additional details are available on the EXEM FOAM KIT profile page.
The generic ingredient in EXEM FOAM KIT is air polymer-type a. There are thirty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the air polymer-type a profile page.
The generic ingredient in EXEM FOAM KIT is air polymer-type a. There are thirty-seven drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the air polymer-type a profile page.
Summary for 212279
| Tradename: | EXEM FOAM KIT |
| Applicant: | Giskit |
| Ingredient: | air polymer-type a |
| Patents: | 3 |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for 212279
Generic Entry Date for 212279*:
Constraining patent/regulatory exclusivity:
NEW CHEMICAL ENTITY Dosage:
FOAM;INTRAUTERINE |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Suppliers and Packaging for NDA: 212279
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| EXEM FOAM KIT | air polymer-type a | FOAM;INTRAUTERINE | 212279 | NDA | GISKIT PHARMA B.V. | 73254-310 | 73254-310-01 | 1 KIT in 1 CARTON (73254-310-01) * 5 mL in 1 SYRINGE, PLASTIC * 5 mL in 1 SYRINGE, PLASTIC |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | FOAM;INTRAUTERINE | Strength | 10ML | ||||
| Approval Date: | Nov 7, 2019 | TE: | RLD: | Yes | |||||
| Regulatory Exclusivity Expiration: | Nov 7, 2024 | ||||||||
| Regulatory Exclusivity Use: | NEW CHEMICAL ENTITY | ||||||||
| Patent: | ⤷ Sign Up | Patent Expiration: | Oct 15, 2030 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patented Use: | USE IN SONOHYSTEROSALPINOGRAPHY TO ASSESS FALLOPIAN TUBE PATENCY | ||||||||
| Patent: | ⤷ Sign Up | Patent Expiration: | May 4, 2035 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
| Patented Use: | USE IN SONOHYSTEROSALPINOGRAPHY TO ASSESS FALLOPIAN TUBE PATENCY | ||||||||
Complete Access Available with Subscription
